Can in vitro assessment provide relevant end points for cognitive drug programs?

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.3, Iss.12, 2008-12, pp. : 1377-1382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro end points for the assessment of cellular immune response-modulating drugs

By Fuggetta Maria Pia Lanzilli Giulia Fioretti Daniela Rinaldi Monica

Expert Opinion on Drug Discovery, Vol. 4, Iss. 5, 2009-05 ,pp. : 473-493

Informa Healthcare

Access to resources Recommend Favorite

In vitro cell culture models for the assessment of pulmonary drug disposition

By Sporty Jennifer L Horálková Lenka Ehrhardt Carsten

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 4, 2008-04 ,pp. : 333-345

Informa Healthcare

Access to resources Recommend Favorite

Update on in vitro cytotoxicity assays for drug development

By Niles Andrew L Moravec Richard A Riss Terry L

Expert Opinion on Drug Discovery, Vol. 3, Iss. 6, 2008-06 ,pp. : 655-669

Informa Healthcare

Access to resources Recommend Favorite

An evaluation of the latest in vitro tools for drug metabolism studies

By Costa Ana Sarmento Bruno Seabra Vítor

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 1, 2014-01 ,pp. : 103-119

Informa Healthcare

Access to resources Recommend Favorite

New in silico and conventional in vitro approaches to advance HIV drug discovery and design

By Maga Giovanni Veljkovic Nevena Crespan Emmanuele Spadari Silvio Prljic Jelena Perovic Vladimir Glisic Sanja Veljkovic Veljko

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 83-92

Informa Healthcare

Access to resources Recommend Favorite